ES8600936A1 - Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these - Google Patents

Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these

Info

Publication number
ES8600936A1
ES8600936A1 ES532055A ES532055A ES8600936A1 ES 8600936 A1 ES8600936 A1 ES 8600936A1 ES 532055 A ES532055 A ES 532055A ES 532055 A ES532055 A ES 532055A ES 8600936 A1 ES8600936 A1 ES 8600936A1
Authority
ES
Spain
Prior art keywords
group
alpha
compounds
hydrogen
androstanecarbothioates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532055A
Other languages
Spanish (es)
Other versions
ES532055A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8600936A1 publication Critical patent/ES8600936A1/en
Publication of ES532055A0 publication Critical patent/ES532055A0/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula < IMAGE > in which R<1> is a fluoro-, chloro- or bromomethyl group or a 2'-fluoroethyl group, R<2> is a group COR<6> in which R<6> is a C1-3-alkyl group, or OR<2> and R<3> together form a 16 alpha ,17 alpha -isopropylidenedioxy group R<3> is a hydrogen atom, a methyl group (which can be present in either the alpha or the ss configuration) or a methylene group R<4> is a hydrogen, chlorine or fluorine atom R<5> is a hydrogen or fluorine atom, and the symbol ..... is a single or double bond. The compounds have good anti-inflammatory activity, in particular on topical application. The compounds of the formula I are prepared by esterification, halogenation, reduction, elimination of protective groups and reaction at a 9,11 double bond to form a 9 alpha -halo-11ss-hydroxy group.
ES532055A 1980-02-15 1984-04-30 PROCEDURE FOR PREPARING ANDROSTAN CARBOTIOATES Granted ES532055A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8005174 1980-02-15
GB8013339 1980-04-23

Publications (2)

Publication Number Publication Date
ES8600936A1 true ES8600936A1 (en) 1985-10-16
ES532055A0 ES532055A0 (en) 1985-10-16

Family

ID=26274505

Family Applications (5)

Application Number Title Priority Date Filing Date
ES499394A Granted ES499394A0 (en) 1980-02-15 1981-02-13 A PROCEDURE FOR PREPARING ANDROSTAN CARBOTIATES
ES509539A Granted ES509539A0 (en) 1980-02-15 1982-02-12 PROCEDURE FOR PREPARING ANDORSTAN CARBOTIOATES.
ES518161A Expired ES8402317A1 (en) 1980-02-15 1982-12-14 Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these
ES524985A Expired ES8502447A1 (en) 1980-02-15 1983-08-16 Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these
ES532055A Granted ES532055A0 (en) 1980-02-15 1984-04-30 PROCEDURE FOR PREPARING ANDROSTAN CARBOTIOATES

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES499394A Granted ES499394A0 (en) 1980-02-15 1981-02-13 A PROCEDURE FOR PREPARING ANDROSTAN CARBOTIATES
ES509539A Granted ES509539A0 (en) 1980-02-15 1982-02-12 PROCEDURE FOR PREPARING ANDORSTAN CARBOTIOATES.
ES518161A Expired ES8402317A1 (en) 1980-02-15 1982-12-14 Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these
ES524985A Expired ES8502447A1 (en) 1980-02-15 1983-08-16 Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these

Country Status (23)

Country Link
KR (1) KR850000969B1 (en)
AT (1) AT395427B (en)
AU (1) AU544517B2 (en)
BG (1) BG60700B2 (en)
CH (2) CH644615A5 (en)
CZ (1) CZ281275B6 (en)
DE (2) DE3105307A1 (en)
DK (1) DK147022C (en)
ES (5) ES499394A0 (en)
FI (1) FI70904C (en)
FR (2) FR2477156A1 (en)
HK (1) HK58385A (en)
IE (1) IE51394B1 (en)
IT (1) IT1170717B (en)
KE (1) KE3526A (en)
MX (1) MX9202717A (en)
MY (1) MY8500757A (en)
NL (2) NL191792C (en)
NZ (1) NZ196260A (en)
PT (1) PT72502B (en)
SE (1) SE452468B (en)
SG (1) SG36885G (en)
SK (1) SK403491A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436549A (en) * 1972-06-15 1976-05-19 Glaxo Lab Ltd 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB1580517A (en) * 1978-04-06 1980-12-03 Fowler I Crutches

Also Published As

Publication number Publication date
SG36885G (en) 1985-11-15
NZ196260A (en) 1983-11-30
MY8500757A (en) 1985-12-31
ATA67481A (en) 1992-05-15
NL191792B (en) 1996-04-01
SK278140B6 (en) 1996-02-07
CZ281275B6 (en) 1996-08-14
DK147022B (en) 1984-03-19
NL191792C (en) 1996-08-02
ES524985A0 (en) 1985-01-01
KE3526A (en) 1985-06-07
DE3105307C2 (en) 1988-09-29
CH644615A5 (en) 1984-08-15
DE3153379C2 (en) 1992-11-19
CZ403491A3 (en) 1994-03-16
PT72502A (en) 1981-03-01
KR830005262A (en) 1983-08-03
MX9202717A (en) 1992-06-30
IE810282L (en) 1981-08-15
FR2485542A1 (en) 1981-12-31
ES8305379A1 (en) 1983-04-01
DK62381A (en) 1981-08-16
IT8147792A0 (en) 1981-02-13
FI70904B (en) 1986-07-18
FI70904C (en) 1986-10-27
ES518161A0 (en) 1984-01-16
SK403491A3 (en) 1996-02-07
ES8207194A1 (en) 1982-09-01
ES532055A0 (en) 1985-10-16
PT72502B (en) 1982-02-05
AU6729881A (en) 1981-08-20
IE51394B1 (en) 1986-12-24
ES509539A0 (en) 1983-04-01
NL960029I1 (en) 1997-02-03
ES8502447A1 (en) 1985-01-01
CH651307A5 (en) 1985-09-13
AU544517B2 (en) 1985-06-06
ES499394A0 (en) 1982-09-01
NL8100707A (en) 1981-09-16
FR2477156A1 (en) 1981-09-04
KR850000969B1 (en) 1985-07-02
SE452468B (en) 1987-11-30
DK147022C (en) 1984-08-27
BG60700B2 (en) 1995-12-29
ES8402317A1 (en) 1984-01-16
DE3105307A1 (en) 1981-12-10
IT1170717B (en) 1987-06-03
FR2477156B1 (en) 1984-11-16
HK58385A (en) 1985-08-16
SE8101010L (en) 1981-08-16
FR2485542B1 (en) 1983-06-10
NL960029I2 (en) 1997-04-01
AT395427B (en) 1992-12-28
FI810444L (en) 1981-08-16

Similar Documents

Publication Publication Date Title
DK159757C (en) APPLICATION OF NAPHTHALENDER DERIVATIVES FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OR PROPHYLACY OF INFLAMMATION BY TOPIC ADMINISTRATION AND PHARMACEUTICAL PREPARATION FOR TOPICAL USE CONTAINING NAPHTHREEN
ATE36699T1 (en) QUINONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL COMPOSITION.
FI810389L (en) FRAMEWORK FOR IMMEDIATE SUBSTITUTION
AU552908B2 (en) 4 n-phenyl benzyl-aminomethyl-imidazole
SE8100134L (en) THERPENOIDS, PROCEDURES FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES8101530A1 (en) beta , gamma -Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
ES8506575A1 (en) New phenylalkanoic acid derivatives, their preparation and use.
ES8600936A1 (en) Androstanecarbothioates, process for their preparation and pharmaceutical compositions containing these
GB1521181A (en) Ketolactones and their manufacture
GB1498919A (en) Furanose-o-pyridylcarboxylic acid esters
ES8308562A1 (en) Polycyclic compounds containing a double bond in the D-ring pharmaceutical compositions containing them, and methods of treating psoriasis with them
MY102090A (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
JPS5422331A (en) Preparation of quinones
ES480869A1 (en) Xylitol derivatives, their preparation and pharmaceutical compositions containing them
JPS5620597A (en) Novel physiologically active substance
JPS55108883A (en) Ethyl-(gamma-acetamino-gamma-ethoxycarbonyl-gamma-cyanopropyl- methyl) phosphinate and its preparation
ES8206435A1 (en) A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition.
ES8307803A1 (en) Polycyclic compounds substituted on the A-ring, pharmaceutical compositions containing them, and methods of treating psoriasis with them
AU550498B2 (en) Derivatives of 3-amino-1-heteroaryloxy-2-propanols
DE3469734D1 (en) Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom
ES8301230A1 (en) Amidotetrazole compounds and processes for their preparation.
GB1494533A (en) 3,15(di-lower alkyl)prostadienoic acid derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050301